Abstract

Cell transplantation has been proposed as a promising therapeutic strategy for curing the diseases requiring tissue repairing and functional restoration. A preclinical method to systematically evaluate the fates of donor cells in recipients, spatially and temporally, is demanded for judging therapeutic potentials for the particularly designed cell transplantation. Yet, the dynamic cell tracking methodology for tracing transplanted cells in vivo is still at its early phase. Here, we created a practical protocol for dynamically tracking cell via a three-dimensional (3D) technique which enabled us to localize, quantify, and overall evaluate the transplanted hepatocytes within a liver failure mouse model. First, the capacity of 3D bioluminescence imaging for quantifying transplanted hepatocytes was defined. Images obtained from the 3D bioluminescence imaging module were then combined with the CT scanner to reconstruct structure images of host mice. With those reconstructed images, precise locations of transplanted hepatocytes in the liver of the recipient were dynamically monitored. Immunohistochemistry staining of transplanted cells, and the serology assay of liver panel of the host mice were applied to verify the successful engraftment of donor cells in the host livers. Our protocol was practical for evaluating the engraftment efficiency of donor cells at their preclinical phases, which is also applicable as a referable standard for studying the fates of other transplanted cells, such as stem cell-derived cell types, during preclinical studies with cell transplantation therapy.

Highlights

  • Today, cell transplantation therapy plays important roles in clinical therapies for many types of diseases

  • Based on the latest generation of instrument for IVIS R Spectrum computed tomography (CT) scanner that combines optical imaging and CT in one platform (Aalipour et al, 2019), we investigated how to establish a practical protocol to perform 3D cell tracking of transplanted hepatocytes in mice

  • Donor hepatocytes expressing luciferase were obtained from the luciferase transgenic mouse generated from our previous study (Wangensteen et al, 2008)

Read more

Summary

Introduction

Cell transplantation therapy plays important roles in clinical therapies for many types of diseases. The current studies in the fields of stem cells and regenerative medicine are hoped to provide the adequate sources of donor cells and bring the cell transplantation therapy into even newer era, which have widely opened the scope to forecast its potential applications into therapies of many injuries or diseases for tissue repairing or replacements. Stem cell-derived functional cells for various tissues are increasingly considered sources of donor cells for cell transplantation therapy in the future. A practical method to track the state and fate of donor cells posttransplantation spatially and temporally is highly demanded in many current and future studies on the preclinical applications of cell transplantation-based therapies (Nguyen et al, 2014)

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.